Nile Pharmaceuticals and Chemical Industries Company (EGX:NIPH)
Egypt · Delayed Price · Currency is EGP 335.00
+9.99 (3.07%)
At close: Nov 12, 2026
EGX:NIPH Ratios and Metrics
Market cap in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 16,750 | 8,202 | 1,465 | 699 | 405 | 359 | |
Market Cap Growth | 392.97% | 459.75% | 109.54% | 72.69% | 12.78% | 1.40% |
Enterprise Value | 18,287 | 9,534 | 2,282 | 1,009 | 670 | 317 |
Last Close Price | 335.00 | 164.03 | 32.01 | 16.84 | 9.08 | 7.38 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 65.34 | 31.99 | 11.65 | 7.75 | 3.40 | 4.00 |
PS Ratio | 7.85 | 3.84 | 1.14 | 0.61 | 0.40 | 0.41 |
PB Ratio | 15.64 | 7.66 | 1.97 | 1.49 | 0.85 | 0.83 |
P/TBV Ratio | 15.64 | 7.66 | 1.97 | 1.49 | 0.85 | 0.83 |
P/OCF Ratio | - | - | 1568.74 | 2.65 | - | 73.13 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 8.57 | 4.47 | 1.77 | 0.88 | 0.67 | 0.36 |
EV/EBITDA Ratio | 30.38 | 15.84 | 8.77 | 6.49 | 1.36 | 2.28 |
EV/EBIT Ratio | 34.17 | 17.81 | 9.85 | 7.03 | 4.11 | 2.53 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 1.45 | 1.45 | 1.33 | 1.23 | 0.44 | 0.19 |
Debt / EBITDA Ratio | 2.58 | 2.58 | 3.80 | 3.70 | 0.43 | 0.57 |
Net Debt / Equity Ratio | 1.44 | 1.44 | 1.30 | 1.15 | 0.40 | 0.06 |
Net Debt / EBITDA Ratio | 2.55 | 2.55 | 3.72 | 3.48 | 0.39 | 0.19 |
Net Debt / FCF Ratio | -2.79 | -2.79 | -2.05 | -3.48 | -0.67 | -0.60 |
Asset Turnover | 0.77 | 0.77 | 0.68 | 0.91 | 1.11 | 1.18 |
Inventory Turnover | 2.54 | 2.54 | 1.82 | 2.08 | 2.26 | 2.62 |
Quick Ratio | 0.22 | 0.22 | 0.27 | 0.35 | 0.47 | 0.57 |
Current Ratio | 1.07 | 1.07 | 0.98 | 1.28 | 1.75 | 1.81 |
Return on Equity (ROE) | 28.26% | 28.26% | 20.75% | 19.05% | 26.22% | 22.36% |
Return on Assets (ROA) | 12.12% | 12.12% | 7.64% | 7.14% | 11.25% | 10.53% |
Return on Invested Capital (ROIC) | 17.42% | 20.34% | 13.13% | 14.25% | 23.69% | 25.38% |
Return on Capital Employed (ROCE) | 34.30% | 34.30% | 20.70% | 17.80% | 30.10% | 28.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 1.53% | 3.13% | 8.58% | 12.90% | 29.44% | 24.98% |
FCF Yield | -3.29% | -6.72% | -32.28% | -22.25% | -70.16% | -12.21% |
Dividend Yield | 0.60% | - | 4.09% | 5.37% | 12.50% | 8.38% |
Payout Ratio | 29.39% | 29.39% | 39.41% | 71.36% | 34.95% | 37.13% |
Buyback Yield / Dilution | -66.67% | -66.67% | -196.30% | - | - | - |
Total Shareholder Return | -66.07% | -66.67% | -192.20% | 5.37% | 12.50% | 8.38% |